AA

Ashwini Anandrao Nikam

Active Director Director DIN 08491494
DIN 08491494 First appointment Jun 2019 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashwini Anandrao Nikam

Data last updated:

Ashwini Anandrao Nikam is a Director at Ajinkya Vet Pharma Private Limited (since 2019). The company operates in Food And Beverages.

DIN 08491494
Primary Designation Director
Industry Food And Beverages
First Appointment 24 Jun 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ajinkya Vet Pharma Private Limited U24309PN2019PTC185013
Director24 Jun 20192019Active

Board colleagues of Ashwini Anandrao Nikam

NameDINCompanyDesignation
Pravinkumar Shahaji Gavali08491493Ajinkya Vet Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ajinkya Vet Pharma Private Limited
Premium access

Shareholding and investment profile for Ashwini Anandrao Nikam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwini Anandrao Nikam

Ashwini Anandrao Nikam currently holds 1 directorship: Ajinkya Vet Pharma Private Limited (Director, since 24 Jun 2019).

Ashwini Anandrao Nikam was first appointed on 24 Jun 2019 as Director at Ajinkya Vet Pharma Private Limited.

The current boards of Ashwini Anandrao Nikam's companies include Pravinkumar Shahaji Gavali (Ajinkya Vet Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available